Neuroimaging clinics of North America
-
Neuroimaging Clin. N. Am. · May 2017
ReviewBrain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.
There is evidence of a neurodegenerative process running in parallel with or as a consequence of the inflammatory phenomenon in multiple sclerosis (MS). MR imaging has been central in the generation of such knowledge and has played a pivotal role in investigating the neurodegenerative process. However, there is insufficient evidence supporting MR imaging-measured brain atrophy as a biomarker of the neurodegenerative component of MS in the daily care of patients with MS. This article discusses the prognostic value of brain volume measurements and their potential role in monitoring treatment response in patients with MS.
-
Neuroimaging Clin. N. Am. · May 2017
ReviewMR Imaging in Monitoring and Predicting Treatment Response in Multiple Sclerosis.
MR imaging is the most sensitive tool for identifying lesions in patients with multiple sclerosis (MS). MR imaging has also acquired an essential role in the detection of complications arising from these treatments and in the assessment and prediction of efficacy. In the future, other radiological measures that have shown prognostic value may be incorporated within the models for predicting treatment response. This article examines the role of MR imaging as a prognostic tool in patients with MS and the recommendations that have been proposed in recent years to monitor patients who are treated with disease-modifying drugs.
-
Increased iron deposition in cerebral deep gray matter has been considered a global marker for neurodegeneration in multiple sclerosis (MS); it scales with disease duration and severity. Iron accumulation in white matter and MS lesions might be more directly related to disease activity and has been discussed as a contributor to the inflammatory and neurodegenerative cascade. ⋯ We discuss findings from MR iron mapping proposed. Because of the confounding magnetic properties of myelin, iron mapping in white matter remains an unresolved issue.
-
Multiple sclerosis is a multifactorial disease with heterogeneous pathogenetic mechanisms, which deserve to be studied to evaluate new possible targets for treatments and improve patient management. MR spectroscopy and PET allow assessing in vivo the molecular and metabolic mechanisms underlying the pathogenesis of multiple sclerosis. This article focuses on the relationship between these imaging techniques and the biologic and chemical pathways leading to multiple sclerosis pathology and its clinical features. Future directions of research are also presented.
-
Neuroimaging Clin. N. Am. · May 2017
ReviewBrain and Spinal Cord MR Imaging Features in Multiple Sclerosis and Variants.
Multiple sclerosis (MS) is a disabling disease, with the first symptoms mostly appearing early in life. In addition to the clinical and laboratory findings, imaging has become increasingly important for diagnosis, prognosis, and monitoring. Because of its importance for these purposes, a high level of knowledge of imaging MS pathology and a standardization of the imaging acquisition, interpretation, and reporting is necessary. Here we will describe the MR imaging characteristics of MS pathology, the current imaging protocols, diagnostic criteria, and the differential diagnosis of MS.